Fresenius Medical Care AG & Co. KGaA (ETR: FME)‘s stock had its “reduce” rating reaffirmed by research analysts at Nomura in a report released on Wednesday. They currently have a $58.44 (€45) target price on the stock.

Fresenius Medical Care AG & Co. KGaA traded down 0.31% on Wednesday, hitting €57.945. Fresenius Medical Care AG & Co. KGaA has a 52-week low of €48.02 and a 52-week high of €60.24.

Separately, analysts at AlphaValue reiterated an “add” rating on shares of Fresenius Medical Care AG & Co. KGaA in a research note to investors on Tuesday. They now have a $76.67 price target on the stock.

Fresenius Medical Care AG & Co KGaA is a Germany-based holding and kidney dialysis company, operating in the fields of dialysis products and dialysis services.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.